XML 14 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Operating Activities:    
Net income $ 405,078 $ 332,769
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 40,418 37,463
Amortization 8,707 8,835
Loss (gain) on sale or disposal of property and equipment 42 (15)
Unrealized foreign currency losses (gains) 1,525 (38,983)
Deferred income taxes 3,301 (11,593)
Stock compensation expense 43,323 37,772
Realized (gains) losses on marketable securities (318) 98
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts 301,791 213,089
Inventories (95,064) (102,239)
Other current and non-current assets (29,068) (17,510)
Accounts payable 3,407 (12,629)
Other current and non-current liabilities (90,378) (57,318)
Deferred revenue (4,483) (8,160)
Deferred costs 2,543 4,102
Income Taxes (54,836) 35,107
Net cash provided by operating activities 535,988 420,788
Investing activities:    
Purchases of property and equipment (66,617) (40,062)
Purchase of marketable securities (333,342) (179,827)
Redemption of marketable securities 147,896 88,788
Net payments for acquisitions 0 (2,100)
Other investing activities, net (307) 599
Net cash used in investing activities (252,370) (132,602)
Financing activities:    
Dividends (173,637) (144,566)
Purchase of treasury shares related to equity awards (46,839) (33,144)
Purchase of treasury shares under share repurchase plan (39,577) (27,098)
Net cash used in financing activities (260,053) (204,808)
Effect of exchange rate changes on cash and cash equivalents (12,286) 12,672
Net increase in cash, cash equivalents, and restricted cash 11,279 96,050
Cash, cash equivalents, and restricted cash at beginning of period 2,279,360 2,080,154
Cash, cash equivalents, and restricted cash at end of period $ 2,290,639 $ 2,176,204